Potassium Fluoride → HCID 66608418, Verbindung

HRID 1625725

Reaktionsgleichung

Reaktionsgleichung von HRID 1625725
Br[CH2:2][C:3]1[N:4]=[N:5][N:6]([C@@H:8]2[O:25][C@H:24]([CH2:26][O:27][C:28](=[O:30])[CH3:29])[C@@H:19]([O:20][C:21](=[O:23])[CH3:22])[C@H:14]([O:15][C:16](=[O:18])[CH3:17])[C@H:9]2[O:10][C:11](=[O:13])[CH3:12])[CH:7]=1.C([Sn](CCCC)(CCCC)[C:36]1[CH:41]=[CH:40][C:39]([CH2:42][CH3:43])=[CH:38][CH:37]=1)CCC.[F-].[K+]>O1CCCC1.C(OCC)(=O)C.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[CH2:42]([C:39]1[CH:40]=[CH:41][C:36]([CH2:2][C:3]2[N:4]=[N:5][N:6]([C@@H:8]3[O:25][C@H:24]([CH2:26][O:27][C:28](=[O:30])[CH3:29])[C@@H:19]([O:20][C:21](=[O:23])[CH3:22])[C@H:14]([O:15][C:16](=[O:18])[CH3:17])[C@H:9]3[O:10][C:11](=[O:13])[CH3:12])[CH:7]=2)=[CH:37][CH:38]=1)[CH3:43]

Komponenten

7

Edukt 3

HCID 522689Potassium FluorideHCID 60041267Tributyl-(4-ethylphenyl)stannaneHCID 666083074-(bromomethyl)-1-(2,3,4,6-tetra-O-acetyl-beta-D-glucopyranosyl)-1,2,3-triazole

Produkt 1

HCID 66608418HCID 66608418, VerbindungAusbeute 17,1 %

Reagenzien, Katalysatoren, Lösungsmittel 3

HCID 178418397HCID 178418397, VerbindungKatalysatorHCID 8028TetrahydrofuranLösungsmittelHCID 8857Ethyl AcetateLösungsmittel

Reaktionsbedingungen

Temperatur
70 °C

Versuchsvorschrift

A solution of 4-(bromomethyl)-1-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-1,2,3-triazole 32 (500 mg) (See Federico G. H. et al., J. Med. Chem. (1979) 29, 496), tri-n-butyl(4-ethylphenyl)tin 33 (604 mg) and tetrakis(triphenylphosphine)palladium (0) (59 mg) in tetrahydrofuran (10 ml) was stirred under heating at 70° C. for 12 hours under argon atmosphere. The reaction mixture was cooled to room temperature, diluted with ethyl acetate, and then, an aqueous potassium fluoride solution was added thereto and the mixture was stirred at room temperature for one hour. Insoluble materials were filtered off, and the filtrate was washed with water, and dried over magnesium sulfate. The solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane:ethyl acetate=90:10-50:50) to give 4-(4-ethylphenylmethyl)-1-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-1,2,3-triazole 34 (90 mg) as a colorless solid. APCI-Mass m/Z 518 (M+H).

Aufarbeitung

  1. temperatureThe reaction mixture was cooled to room temperature
  2. filtrationInsoluble materials were filtered off
  3. washthe filtrate was washed with water
  4. dry with materialdried over magnesium sulfate
  5. customThe solvent was evaporated under reduced pressure
  6. customThe residue was purified by silica gel column chromatography (hexane:ethyl acetate=90:10-50:50)

Quellen und Nachweise

ORD-Eintrag
ord-4c60b556211e479ba1a287acf006ada8
Quelldatensatz
uspto-grants-2014_07
Patentnummer
US08785403B2

Verknüpfte Notizen

Wird geladen…